Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2015 Dec 2;5:271. doi: 10.3389/fonc.2015.00271

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

Thomas Paul Slavin 1,*, Mariana Niell-Swiller 1, Ilana Solomon 1, Bita Nehoray 1, Christina Rybak 1, Kathleen R Blazer 1, Jeffrey N Weitzel 1
PMCID: PMC4667011  PMID: 26697406

On page 4 of our manuscript, line 528, there is an erroneous reference for Figure 3.

“Mosaic TP53

Case 2 is a 42-year-old unaffected woman of Northern European ancestry referred for interpretation of ambiguous results from a breast focused multigene panel ordered by her referring physician due to her maternal family history of cancer (Figure 3);”

Figure 3 only pertains to the CDH1 case above (correctly referenced there). Therefore, the sentence should read:

“Case 2 is a 42-year-old unaffected woman of Northern European ancestry referred for interpretation of ambiguous results from a breast focused multigene panel ordered by her referring physician due to her maternal family history of cancer;”

We apologize for any confusion this may have caused.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES